144 related articles for article (PubMed ID: 11159535)
1. Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides.
Capoulade C; Mir LM; Carlier K; Lécluse Y; Tétaud C; Mishal Z; Wiels J
Blood; 2001 Feb; 97(4):1043-9. PubMed ID: 11159535
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.
Capoulade C; Bressac-de Paillerets B; Lefrère I; Ronsin M; Feunteun J; Tursz T; Wiels J
Oncogene; 1998 Mar; 16(12):1603-10. PubMed ID: 9569028
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression.
Chen L; Lu W; Agrawal S; Zhou W; Zhang R; Chen J
Mol Med; 1999 Jan; 5(1):21-34. PubMed ID: 10072445
[TBL] [Abstract][Full Text] [Related]
4. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
[TBL] [Abstract][Full Text] [Related]
5. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
Lindström MS; Klangby U; Wiman KG
Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
[TBL] [Abstract][Full Text] [Related]
6. MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells.
Urashima M; Teoh G; Chauhan D; Ogata A; Shirahama S; Kaihara C; Matsuzaki M; Matsushima H; Akiyama M; Yuza Y; Maekawa K; Anderson KC
Blood; 1998 Aug; 92(3):959-67. PubMed ID: 9680365
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage.
Chen L; Agrawal S; Zhou W; Zhang R; Chen J
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):195-200. PubMed ID: 9419352
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1.
Sato N; Mizumoto K; Maehara N; Kusumoto M; Nishio S; Urashima T; Ogawa T; Tanaka M
Anticancer Res; 2000; 20(2A):837-42. PubMed ID: 10810363
[TBL] [Abstract][Full Text] [Related]
9. TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.
Leventaki V; Rodic V; Tripp SR; Bayerl MG; Perkins SL; Barnette P; Schiffman JD; Miles RR
Br J Haematol; 2012 Sep; 158(6):763-71. PubMed ID: 22845047
[TBL] [Abstract][Full Text] [Related]
10. The pathway regulating MDM2 protein degradation can be altered in human leukemic cells.
Pan Y; Haines DS
Cancer Res; 1999 May; 59(9):2064-7. PubMed ID: 10232588
[TBL] [Abstract][Full Text] [Related]
11. RB18A regulates p53-dependent apoptosis.
Frade R; Balbo M; Barel M
Oncogene; 2002 Jan; 21(6):861-6. PubMed ID: 11840331
[TBL] [Abstract][Full Text] [Related]
12. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M
Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655
[TBL] [Abstract][Full Text] [Related]
13. The loss of mdm2 induces p53-mediated apoptosis.
de Rozieres S; Maya R; Oren M; Lozano G
Oncogene; 2000 Mar; 19(13):1691-7. PubMed ID: 10763826
[TBL] [Abstract][Full Text] [Related]
14. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
15. Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma.
Iyer R; Ding L; Batchu RB; Naugler S; Shammas MA; Munshi NC
Leuk Res; 2003 Jan; 27(1):73-8. PubMed ID: 12479855
[TBL] [Abstract][Full Text] [Related]
16. Activation of p53 in MDM2-overexpressing cells through phosphorylation.
Gao C; Nakajima T; Taya Y; Tsuchida N
Biochem Biophys Res Commun; 1999 Nov; 264(3):860-4. PubMed ID: 10544021
[TBL] [Abstract][Full Text] [Related]
17. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells.
Dilla T; Velasco JA; Medina DL; González-Palacios JF; Santisteban P
Endocrinology; 2000 Jan; 141(1):420-9. PubMed ID: 10614665
[TBL] [Abstract][Full Text] [Related]
18. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
[TBL] [Abstract][Full Text] [Related]
19. UV but not gamma irradiation accelerates p53-induced apoptosis of teratocarcinoma cells by repressing MDM2 transcription.
Zeng X; Keller D; Wu L; Lu H
Cancer Res; 2000 Nov; 60(21):6184-8. PubMed ID: 11085543
[TBL] [Abstract][Full Text] [Related]
20. Differential p53, p21, mdm2 and Rb regulation in glioma cell lines that overexpress wild-type p53.
Pykett MJ; Azzam E; Dahlberg W; Little JB
Int J Oncol; 1998 Aug; 13(2):213-6. PubMed ID: 9664113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
